SEARCH:   Advanced

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by De Re, V. Articles by Boiocchi, M. Search for Related Content PubMed PubMed Citation Articles by De Re, V. Articles by Boiocchi, M. Related Collections Immunobiology Neoplasia Related Letter in Blood Online Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 15 November 2000, Vol. 96, No. 10, pp. 3578-3584 NEOPLASIA Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia Valli De Re, Salvatore De Vita, Alessandra Marzotto, Maurizio Rupolo, Annunziata Gloghini, Barbara Pivetta, Daniela Gasparotto, Antonino Carbone, and Mauro Boiocchi From the Divisions of Experimental Oncology 1, Medical Oncology, and Pathology, Centro di Riferimento Oncologico, Aviano, Italy; Chair and Division of Rheumatology, DPMSC, University of Udine, Udine, Italy. Analysis of the immunoglobulin receptor (IGR) variable heavy- and light-chain sequences on 17 hepatitis C virus (HCV)-associated non-Hodgkin lymphomas (NHLs) (9 patients also had type II mixed cryoglobulinemia [MC] syndrome and 8 had NHL unrelated to MC) and analysis of intraclonal diversity on 8 of them suggest that such malignant lymphoproliferations derive from an antigen-driven pathologic process, with a selective pressure for the maintenance of a functional IgR and a negative pressure for additional amino acid mutations in the framework regions (FRs). For almost all NHLs, both heavy- and light-chain complementarity-determining regions (CDR3) showed the highest similarity to antibodies with rheumatoid factor (RF) activity that have been found in the MC syndrome, thus suggesting that a common antigenic stimulus is involved in MC syndrome and in HCV-associated lymphomagenesis. Moreover, because HCV is the recognized pathologic agent of MC and the CDR3 amino acid sequences of some HCV-associated NHLs also present a high homology for antibody specific for the E2 protein of HCV, it may be reasonable to speculate that HCV E2 protein is one of the chronic antigenic stimuli involved in the lymphomagenetic process. Finally, the use of specific segments, in particular the D segment, in assembling the IgH chain of IgR seems to confer B-cell disorders with the property to produce antibody with RF activity, which may contribute to the manifestation of an overt MC syndrome. © 2000 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Letter in Blood Online: WA monoclonal rheumatoid factors and non-Hodgkin lymphoma Glenn Knight, Vincent Agnello, Mauro Boiocchi, Valli De Re, Daniela Gasparotto, and Salvatore De Vita Blood 2001 97: 3319-3321. [Full Text] [PDF] This article has been cited by other articles: A. Dagklis, C. Fazi, C. Sala, V. Cantarelli, C. Scielzo, R. Massacane, D. Toniolo, F. Caligaris-Cappio, K. Stamatopoulos, and P. Ghia The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring Blood, July 2, 2009; 114(1): 26 - 32. [Abstract] [Full Text] [PDF] V. De Re, S. De Vita, D. Sansonno, and G. Toffoli Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development Blood, June 15, 2008; 111(12): 5760 - 5760. [Full Text] [PDF] D. Saadoun, M. Rosenzwajg, D. Landau, J. C. Piette, D. Klatzmann, and P. Cacoub Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis Blood, June 1, 2008; 111(11): 5334 - 5341. [Abstract] [Full Text] [PDF] E. D. Charles, R. M. Green, S. Marukian, A. H. Talal, G. V. Lake-Bakaar, I. M. Jacobson, C. M. Rice, and L. B. Dustin Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia Blood, February 1, 2008; 111(3): 1344 - 1356. [Abstract] [Full Text] [PDF] M Fabris, L Quartuccio, S Salvin, G Pozzato, V De Re, C Mazzaro, C Ferri, C Baldini, and S De Vita Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia Ann Rheum Dis, January 1, 2008; 67(1): 80 - 83. [Abstract] [Full Text] [PDF] D S Viswanatha and A Dogan Hepatitis C virus and lymphoma J. Clin. Pathol., December 1, 2007; 60(12): 1378 - 1383. [Abstract] [Full Text] [PDF] C. Krishnan, J. S. Cupp, D. A. Arber, and J. D. Faix Lymphoplasmacytic Lymphoma Arising in the Setting of Hepatitis C and Mixed Cryoglobulinemia J. Clin. Oncol., September 20, 2007; 25(27): 4312 - 4314. [Full Text] [PDF] D. Saadoun, D. A. Landau, L. H. Calabrese, and P. P. Cacoub Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation Rheumatology, August 1, 2007; 46(8): 1234 - 1242. [Abstract] [Full Text] [PDF] D. Sansonno, A. Carbone, V. De Re, and F. Dammacco Hepatitis C virus infection, cryoglobulinaemia, and beyond Rheumatology, April 1, 2007; 46(4): 572 - 578. [Abstract] [Full Text] [PDF] M. Fabris, L. Quartuccio, S. Sacco, G. De Marchi, G. Pozzato, C. Mazzaro, G. Ferraccioli, T. S. Migone, and S. De Vita B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection Rheumatology, January 1, 2007; 46(1): 37 - 43. [Abstract] [Full Text] [PDF] K. Stamatopoulos, C. Belessi, C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations Blood, January 1, 2007; 109(1): 259 - 270. [Abstract] [Full Text] [PDF] G. Merlini and M. J. Stone Dangerous small B-cell clones Blood, October 15, 2006; 108(8): 2520 - 2530. [Abstract] [Full Text] [PDF] V. De Re, S. De Vita, D. Sansonno, D. Gasparotto, M. P. Simula, F. A. Tucci, A. Marzotto, M. Fabris, A. Gloghini, A. Carbone, et al. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses Rheumatology, June 1, 2006; 45(6): 685 - 693. [Abstract] [Full Text] [PDF] F. Suarez, O. Lortholary, O. Hermine, and M. Lecuit Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation Blood, April 15, 2006; 107(8): 3034 - 3044. [Abstract] [Full Text] [PDF] V. Racanelli, M. A. Frassanito, P. Leone, M. Galiano, V. De Re, F. Silvestris, and F. Dammacco Antibody Production and In Vitro Behavior of CD27-Defined B-Cell Subsets: Persistent Hepatitis C Virus Infection Changes the Rules. J. Virol., April 1, 2006; 80(8): 3923 - 3934. [Abstract] [Full Text] [PDF] M. Carbonari, E. Caprini, T. Tedesco, F. Mazzetta, V. Tocco, M. Casato, G. Russo, and M. Fiorilli Hepatitis C Virus Drives the Unconstrained Monoclonal Expansion of VH1-69-Expressing Memory B Cells in Type II Cryoglobulinemia: A Model of Infection-Driven Lymphomagenesis J. Immunol., May 15, 2005; 174(10): 6532 - 6539. [Abstract] [Full Text] [PDF] R. J. Bende, W. M. Aarts, R. G. Riedl, D. de Jong, S. T. Pals, and C. J.M. van Noesel Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity J. Exp. Med., April 18, 2005; 201(8): 1229 - 1241. [Abstract] [Full Text] [PDF] J. Q. Zhang, C. Okumura, T. McCarty, M. S. Shin, P. Mukhopadhyay, M. Hori, T. A. Torrey, Z. Naghashfar, J. X. Zhou, C. H. Lee, et al. Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl J. Exp. Med., December 6, 2004; 200(11): 1467 - 1478. [Abstract] [Full Text] [PDF] S. Zompi, L.-J. Couderc, J. Cadranel, M. Antoine, B. Epardeau, J. Fleury-Feith, N. Popa, F. Santoli, J.-P. Farcet, and M.-H. Delfau-Larue Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma Blood, April 15, 2004; 103(8): 3208 - 3215. [Abstract] [Full Text] [PDF] L. M. Morton, E. A. Engels, T. R. Holford, B. Leaderer, Y. Zhang, S. H. Zahm, P. Boyle, B. Zhang, S. Flynn, G. Tallini, et al. Hepatitis C Virus and Risk of Non-Hodgkin Lymphoma: A Population-Based Case-Control Study among Connecticut Women Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 425 - 430. [Abstract] [Full Text] N. C. Turner, G. Dusheiko, and A. Jones Hepatitis C and B-cell lymphoma Ann. Onc., September 1, 2003; 14(9): 1341 - 1345. [Abstract] [Full Text] [PDF] A. Mele, A. Pulsoni, E. Bianco, P. Musto, A. Szklo, M. G. Sanpaolo, E. Iannitto, A. De Renzo, B. Martino, V. Liso, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study Blood, August 1, 2003; 102(3): 996 - 999. [Abstract] [Full Text] [PDF] D. Sansonno, V. De Re, G. Lauletta, F. A. Tucci, M. Boiocchi, and F. Dammacco Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20 Blood, May 15, 2003; 101(10): 3818 - 3826. [Abstract] [Full Text] [PDF] F. Zaja, S. De Vita, C. Mazzaro, S. Sacco, D. Damiani, G. De Marchi, A. Michelutti, M. Baccarani, R. Fanin, and G. Ferraccioli Efficacy and safety of rituximab in type II mixed cryoglobulinemia Blood, May 15, 2003; 101(10): 3827 - 3834. [Abstract] [Full Text] [PDF] J. Ni, E. Hembrador, A. M. Di Bisceglie, I. M. Jacobson, A. H. Talal, D. Butera, C. M. Rice, T. J. Chambers, and L. B. Dustin Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients J. Immunol., March 15, 2003; 170(6): 3429 - 3439. [Abstract] [Full Text] [PDF] O. Hermine, F. Lefrere, J.-P. Bronowicki, X. Mariette, K. Jondeau, V. Eclache-Saudreau, B. Delmas, F. Valensi, P. Cacoub, C. Brechot, et al. Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection N. Engl. J. Med., July 11, 2002; 347(2): 89 - 94. [Abstract] [Full Text] [PDF] M. Casato, C. Mecucci, V. Agnello, M. Fiorilli, G. B. Knight, C. Matteucci, L. Gao, and J. Kay Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia Blood, March 15, 2002; 99(6): 2259 - 2261. [Abstract] [Full Text] [PDF] E. R. Quinn, C. H. Chan, K. G. Hadlock, S. K. H. Foung, M. Flint, and S. Levy The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis Blood, December 15, 2001; 98(13): 3745 - 3749. [Abstract] [Full Text] [PDF] M. Gerotto, F. Dal Pero, S. Loffreda, F. B. Bianchi, A. Alberti, and M. Lenzi A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2 Blood, November 1, 2001; 98(9): 2657 - 2663. [Abstract] [Full Text] [PDF] V. Racanelli, D. Sansonno, C. Piccoli, F. P. D'Amore, F. A. Tucci, and F. Dammacco Molecular Characterization of B Cell Clonal Expansions in the Liver of Chronically Hepatitis C Virus-Infected Patients J. Immunol., July 1, 2001; 167(1): 21 - 29. [Abstract] [Full Text] [PDF] G. Knight, V. Agnello, M. Boiocchi, V. De Re, D. Gasparotto, and S. De Vita WA monoclonal rheumatoid factors and non-Hodgkin lymphoma Blood, May 15, 2001; 97(10): 3319 - 3321. [Full Text] [PDF] F. Cavalli, P. G. Isaacson, R. D. Gascoyne, and E. Zucca MALT Lymphomas Hematology, January 1, 2001; 2001(1): 241 - 258. [Abstract] [Full Text] [PDF]

	Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020